Showing results (271-280 of 329) with videos related to
Sort By:
Pageof 33
Journal of the American Society of Nephrology : JASN|July 17, 2021
Effects of Dapagliflozin in Stage 4 Chronic Kidney DiseaseGlenn M Chertow, Priya Vart, Niels Jongs, et al.European Heart Journal|April 1, 2021
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trialHiddo J L Heerspink, C David Sjöström, Niels Jongs, et al.Kidney International Supplements|March 10, 2020
Framework for establishing integrated kidney care programs in low- and middle-income countriesMarcello Tonelli, Victoria Nkunu, Cherian Varghese, et al.Clinical Pharmacology and Therapeutics|December 18, 2020
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney DiseaseJeroen V Koomen, Jasper Stevens, George Bakris, et al.The New England Journal of Medicine|September 24, 2020
Dapagliflozin in Patients with Chronic Kidney DiseaseHiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, et al.American Journal of Nephrology|February 17, 2021
Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance HemodialysisJianping Jiang, Yuanyuan Zhang, Jianghua Chen, et al.Journal of Lipid Research|November 24, 2016
Association of peripheral differential leukocyte counts with dyslipidemia risk in Chinese patients with hypertension: insight from the China Stroke Primary Prevention TrialYanhong Liu, Xiangyi Kong, Wen Wang, et al.Theranostics|October 24, 2022
A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cellsCanzhen Liu, Xiaoxu Wang, Xiaonan Wang, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trialDavid C Wheeler, Niels Jongs, Bergur V Stefansson, et al.Investigative Ophthalmology & Visual Science|July 20, 2021
Hypertensive Retinopathy and the Risk of Stroke Among Hypertensive Adults in ChinaXuling Chen, Lishun Liu, Mengyi Liu, et al.Pageof 33